Alta Partners, a global investment company, led a $13.5m Series A round in Free Market Health, a healthcare technology company, with participation from Highmark Ventures and 653 Investment Partners. "From delays in prior authorization requests to uncertainty on the best fit specialty pharmacy and medication pricing variability, the existing specialty pharmacy ecosystem fails to do what it’s meant to do: efficiently deliver lifesaving and life-altering medications into the hands of patients. Our mission is to ensure the specialty medication referral and reimbursement process never fails the patient, and we’re thrilled to have support from innovative and passionate investors like Alta Partners, Highmark Ventures and 653 Investment Partners," Joe Cardosi, Free Market Health Founder and Chief Executive Officer.